| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $139.9M | +57.1% |
| Cost of Revenue | $41.0M | +16.1% |
| Gross Profit | $98.9M | +84.0% |
| R&D Expense | $34.4M | +18.3% |
| SG&A Expense | $101.4M | +35.6% |
| Operating Income | -$36.9M | +26.4% |
| Interest Expense | $21K | -99.4% |
| Pre-tax Income | -$27.4M | +43.6% |
| Income Tax | $50K |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.7M | +72.4% |
| Short-term Investments | $220.5M | +87.7% |
| Accounts Receivable | $30.1M | +48.2% |
| Inventory | $22.0M | +26.3% |
| Current Assets | $293.8M | +74.5% |
| Total Assets | $318.6M | +74.5% |
| Current Liabilities | $25.9M | +23.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.9M | +59.3% |
| Capital Expenditures | $5.4M | +13.0% |
| Investing Cash Flow | -$99.3M | -348.8% |
| Financing Cash Flow | $123.3M | +100.4% |
| Free Cash Flow | -$22.4M | +51.8% |
| +150.0% |
| Net Income | -$27.5M | +43.5% |
| EPS (Basic) | -$0.71 | +49.6% |
| EPS (Diluted) | -$0.71 | +49.6% |
| Total Liabilities |
| $37.3M |
| +68.2% |
| Stockholders' Equity | $281.2M | +75.4% |